{"id":254713,"date":"2026-09-18T09:30:47","date_gmt":"2026-09-18T04:00:47","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=254713"},"modified":"2026-09-18T09:30:47","modified_gmt":"2026-09-18T04:00:47","slug":"alivus-life-sciences-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/","title":{"rendered":"Is Alivus Life Sciences the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Alivus Life Sciences CMP Rs 1,388 (18 Sep 2026). Market cap Rs 17,029 Cr. ROE 16.94%. P\/E 28.24x versus Industry P\/E 50.18x.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Alivus Life Sciences is one of the names investors compare when screening the Healthcare sector, built on a 16.94% return on equity and a P\/E of 28.24x against an Industry P\/E of 50.18x. Whether Alivus Life Sciences is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n<p>Is <a href=\"https:\/\/univest.in\/stocks\/alivus\/alivus-life-sciences-ltd-share-price-today\">Alivus Life Sciences<\/a> the best stock in its sector? The stock trades on the NSE at Rs 1,388 as of 18 September 2026, within its 52-week range of Rs 819.00 to Rs 1,493.80. Alivus Life Sciences Ltd, formerly Glenmark Life Sciences, manufactures active pharmaceutical ingredients for global pharmaceutical customers.<\/p>\n<p>Alivus Life Sciences sits in the Healthcare sector, and its 16.94% ROE and 28.24x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector&#8217;s Industry P\/E benchmark.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/abbott-india-best-stock-in-its-sector\">Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=alivus-life-sciences-best-stock-in-its-sector\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#About_Alivus_Life_Sciences\" title=\"About Alivus Life Sciences\">About Alivus Life Sciences<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#Is_Alivus_Life_Sciences_the_Best_Stock_in_Its_Sector\" title=\"Is Alivus Life Sciences the Best Stock in Its Sector?\">Is Alivus Life Sciences the Best Stock in Its Sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#How_Alivus_Life_Sciences_Compares_Against_Its_Healthcare_Sector_Peers\" title=\"How Alivus Life Sciences Compares Against Its Healthcare Sector Peers\">How Alivus Life Sciences Compares Against Its Healthcare Sector Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#What_Makes_Alivus_Life_Sciences_Worth_Watching_in_Healthcare\" title=\"What Makes Alivus Life Sciences Worth Watching in Healthcare\">What Makes Alivus Life Sciences Worth Watching in Healthcare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#Alivus_Life_Sciences_Valuation_Is_It_Justified\" title=\"Alivus Life Sciences Valuation: Is It Justified?\">Alivus Life Sciences Valuation: Is It Justified?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#How_to_Track_Alivus_Life_Sciences_Before_You_Invest\" title=\"How to Track Alivus Life Sciences Before You Invest\">How to Track Alivus Life Sciences Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#Is_Alivus_Life_Sciences_the_best_stock_in_its_sector\" title=\"Is Alivus Life Sciences the best stock in its sector?\">Is Alivus Life Sciences the best stock in its sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#What_is_the_current_share_price_of_Alivus_Life_Sciences\" title=\"What is the current share price of Alivus Life Sciences?\">What is the current share price of Alivus Life Sciences?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#What_sector_does_Alivus_Life_Sciences_belong_to\" title=\"What sector does Alivus Life Sciences belong to?\">What sector does Alivus Life Sciences belong to?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#How_does_Alivus_Life_Sciences_compare_to_its_sector_peers_on_PE\" title=\"How does Alivus Life Sciences compare to its sector peers on P\/E?\">How does Alivus Life Sciences compare to its sector peers on P\/E?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#What_is_Alivus_Life_Sciencess_return_on_equity\" title=\"What is Alivus Life Sciences&#8217;s return on equity?\">What is Alivus Life Sciences&#8217;s return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/alivus-life-sciences-best-stock-in-its-sector\/#Should_I_invest_in_Alivus_Life_Sciences_based_on_its_sector_position\" title=\"Should I invest in Alivus Life Sciences based on its sector position?\">Should I invest in Alivus Life Sciences based on its sector position?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Alivus_Life_Sciences\"><\/span><strong>About Alivus Life Sciences<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alivus Life Sciences Ltd, formerly Glenmark Life Sciences, manufactures active pharmaceutical ingredients for global pharmaceutical customers. It was renamed from Glenmark Life Sciences after the Nirma Group acquired a majority stake, and manufactures active pharmaceutical ingredients for global pharma customers. At a market capitalisation of Rs 17,029 Cr, it is tracked as part of the Healthcare sector on Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Alivus_Life_Sciences_the_Best_Stock_in_Its_Sector\"><\/span><strong>Is Alivus Life Sciences the Best Stock in Its Sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alivus Life Sciences makes its case as the best stock in its sector primarily on return on equity and balance sheet strength, combining a 16.94% ROE with a 28.24x P\/E against the sector&#8217;s 50.18x Industry P\/E. Alivus Life Sciences&#8217; 28.24x P\/E is well below the 50.18x Industry P\/E despite a 16.94% ROE ahead of Akums Drugs and Pharmaceuticals in this comparison, making it look inexpensive relative to its own quality among the CDMO and API peers covered in this series.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Metric<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Alivus Life Sciences<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">CMP (NSE)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 1,387.80<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">52-Week High \/ Low<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 1,493.80 \/ Rs 819.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Market Cap<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 17,029 Cr<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">P\/E (TTM) vs Industry P\/E<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">28.24x vs 50.18x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">P\/B<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">5.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">ROE<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">16.94%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">EPS (TTM)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 49.12<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Dividend Yield<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.36%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Debt to Equity<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.02<\/td>\n<\/tr>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Alivus Life Sciences Against Other Healthcare Sector Stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Alivus_Life_Sciences_Compares_Against_Its_Healthcare_Sector_Peers\"><\/span><strong>How Alivus Life Sciences Compares Against Its Healthcare Sector Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets Alivus Life Sciences against 3 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P\/E, ROE and debt to equity, calculated across the 3 peer companies.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Company<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">P\/E<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/alivus\/alivus-life-sciences-ltd-share-price-today\">Alivus Life Sciences<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">17,029<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">28.24<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">16.94%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.02<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/akums\/akums-drugs-and-pharmaceuticals-ltd-share-price-today\">Akums Drugs and Pharmaceuticals<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">12,059<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">41.19<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">7.70%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sailife\/sai-life-sciences-ltd-share-price-today\">Sai Life Sciences<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">32,723<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">90.47<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">14.05%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.12<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/gland\/gland-pharma-ltd-share-price-today\">Gland Pharma<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">48,215<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">42.71<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">9.92%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.03<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>Peer average (3 companies)<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">&#8211;<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>58.12<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>10.56%<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>0.07<\/strong><\/td>\n<\/tr>\n<\/table>\n<p>Against this peer set, Alivus Life Sciences&#8217;s 16.94% ROE is above the 10.56% peer average, and its P\/E of 28.24x runs below the peer average of 58.12x. Alivus Life Sciences&#8217; 28.24x P\/E is well below the 50.18x Industry P\/E despite a 16.94% ROE ahead of Akums Drugs and Pharmaceuticals in this comparison, making it look inexpensive relative to its own quality among the CDMO and API peers covered in this series.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Makes_Alivus_Life_Sciences_Worth_Watching_in_Healthcare\"><\/span><strong>What Makes Alivus Life Sciences Worth Watching in Healthcare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Well below Industry P\/E:<\/strong> A 28.24x P\/E against a 50.18x Industry P\/E is a significant discount for an API manufacturer with a 16.94% ROE.<\/li>\n<li><strong>Near debt free:<\/strong> A debt to equity ratio of 0.02 gives Alivus Life Sciences flexibility to invest in manufacturing capacity.<\/li>\n<li><strong>Global API manufacturing scale:<\/strong> Manufacturing active pharmaceutical ingredients for global pharma customers gives Alivus Life Sciences a diversified, export-oriented customer base.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Alivus_Life_Sciences_Valuation_Is_It_Justified\"><\/span><strong>Alivus Life Sciences Valuation: Is It Justified?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alivus Life Sciences&#8217; 28.24x P\/E is well below the 50.18x Industry P\/E despite a 16.94% ROE ahead of Akums Drugs and Pharmaceuticals in this comparison, making it look inexpensive relative to its own quality among the CDMO and API peers covered in this series. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/aditya-birla-lifestyle-brands-best-stock-in-its-sector\">Is Aditya Birla Lifestyle Brands the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Alivus Life Sciences and other Healthcare sector stocks.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Track_Alivus_Life_Sciences_Before_You_Invest\"><\/span><strong>How to Track Alivus Life Sciences Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Before deciding whether Alivus Life Sciences deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.<\/p>\n<ol>\n<li>Open the Univest Screener and search for Alivus Life Sciences to view live price, valuation ratios, and peer comparisons within the Healthcare sector.<\/li>\n<li>Compare its P\/E, P\/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.<\/li>\n<li>Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.<\/li>\n<li>Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alivus Life Sciences earns a place in the best stock in its sector conversation on the strength of a 16.94% ROE and a P\/E of 28.24x against a 50.18x Industry P\/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h3><span class=\"ez-toc-section\" id=\"Is_Alivus_Life_Sciences_the_best_stock_in_its_sector\"><\/span><strong>Is Alivus Life Sciences the best stock in its sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alivus Life Sciences has a 16.94% ROE and trades at 28.24x P\/E against a 50.18x Industry P\/E, and compares above the peer average ROE of 10.56% in this article&#8217;s named comparison, so the answer depends on what an investor is prioritising.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Alivus_Life_Sciences\"><\/span><strong>What is the current share price of Alivus Life Sciences?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alivus Life Sciences was trading at Rs 1,387.80 on the NSE as of 18 September 2026, within its 52-week range of Rs 819.00 to Rs 1,493.80.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Alivus_Life_Sciences_belong_to\"><\/span><strong>What sector does Alivus Life Sciences belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alivus Life Sciences is classified under the Healthcare sector on Univest.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Alivus_Life_Sciences_compare_to_its_sector_peers_on_PE\"><\/span><strong>How does Alivus Life Sciences compare to its sector peers on P\/E?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alivus Life Sciences&#8217;s P\/E of 28.24x is below the 58.12x average of the 3 named peers compared in this article.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Alivus_Life_Sciencess_return_on_equity\"><\/span><strong>What is Alivus Life Sciences&#8217;s return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alivus Life Sciences reported a return on equity of 16.94%, which is above the 10.56% average of its named peers in this comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_invest_in_Alivus_Life_Sciences_based_on_its_sector_position\"><\/span><strong>Should I invest in Alivus Life Sciences based on its sector position?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alivus Life Sciences&#8217;s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Is Alivus Life Sciences the best stock in its sector?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alivus Life Sciences has a 16.94% ROE and trades at 28.24x P\/E against a 50.18x Industry P\/E, and compares above the peer average ROE of 10.56% in this article's named comparison, so the answer depends on what an investor is prioritising.\"}},{\"@type\":\"Question\",\"name\":\"What is the current share price of Alivus Life Sciences?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alivus Life Sciences was trading at Rs 1,387.80 on the NSE as of 18 September 2026, within its 52-week range of Rs 819.00 to Rs 1,493.80.\"}},{\"@type\":\"Question\",\"name\":\"What sector does Alivus Life Sciences belong to?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alivus Life Sciences is classified under the Healthcare sector on Univest.\"}},{\"@type\":\"Question\",\"name\":\"How does Alivus Life Sciences compare to its sector peers on P\/E?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alivus Life Sciences's P\/E of 28.24x is below the 58.12x average of the 3 named peers compared in this article.\"}},{\"@type\":\"Question\",\"name\":\"What is Alivus Life Sciences's return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alivus Life Sciences reported a return on equity of 16.94%, which is above the 10.56% average of its named peers in this comparison.\"}},{\"@type\":\"Question\",\"name\":\"Should I invest in Alivus Life Sciences based on its sector position?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alivus Life Sciences's sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Is Alivus Life Sciences the best stock in its sector? A data-backed look at its ROE, valuation and named Healthcare sector peer comparison.<\/p>\n","protected":false},"author":29,"featured_media":254712,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[5839,1019],"class_list":["post-254713","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-sector-stocks","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["254712"],"rank_math_title":["Alivus Life Sciences: Best Stock in Its Sector? Key Metrics"],"rank_math_description":["Is Alivus Life Sciences the best stock in its sector? Check CMP, ROE, PE versus Industry PE, debt levels and peer comparisons before deciding on this Healthcare sector stock."],"rank_math_focus_keyword":["best stock in its sector"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/alivus-life-sciences-best-stock-in-its-sector.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/254713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=254713"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/254713\/revisions"}],"predecessor-version":[{"id":254714,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/254713\/revisions\/254714"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/254712"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=254713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=254713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=254713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}